Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76051 - 76075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sulindac	Approved Investigational	ATF3	467	upregulated	Sulindac results in increased expression of ATF3 mRNA	1q32.3	A20927
Sulindac	Approved Investigational	ATF4	468	upregulated	Sulindac results in increased expression of ATF4 mRNA	22q13.1	A20927
Sulindac	Approved Investigational	ATP2A1	487	downregulated	Sulindac results in decreased expression of ATP2A1 mRNA	16p11.2	A20927
Sulindac	Approved Investigational	AURKA	6790	downregulated	Sulindac results in decreased expression of AURKA mRNA	20q13.2	A20927
Sulindac	Approved Investigational	BBC3	27113	upregulated	Sulindac results in increased expression of BBC3 mRNA	19q13.32	A20927
Sulindac	Approved Investigational	BCAP29	55973	upregulated	Sulindac results in increased expression of BCAP29 mRNA	7q22.3	A20927
Sulindac	Approved Investigational	BIRC5	332	downregulated	Sulindac results in decreased expression of BIRC5 mRNA	17q25.3	A20927 A24349
Sulindac	Approved Investigational	BRCA1	672	downregulated	Sulindac results in decreased expression of BRCA1 mRNA	17q21.31	A24350
Sulindac	Approved Investigational	BRD4	23476	downregulated	Sulindac results in decreased expression of BRD4 mRNA	19p13.12	A20927
Sulindac	Approved Investigational	BZW2	28969	downregulated	Sulindac results in decreased expression of BZW2 mRNA	7p21.1	A24351
Sulindac	Approved Investigational	CA9	768	downregulated	Sulindac analog results in decreased expression of CA9 mRNA	9p13.3	A23447
Sulindac	Approved Investigational	CALM3	808	downregulated	Sulindac results in decreased expression of CALM3 mRNA	19q13.32	A20927
Sulindac	Approved Investigational	CCNB1	891	downregulated	Sulindac results in decreased expression of CCNB1 mRNA	5q13.2	A20927
Sulindac	Approved Investigational	CCNJ	54619	downregulated	Sulindac results in decreased expression of CCNJ mRNA	10q24.1	A20927
Sulindac	Approved Investigational	CDC42EP1	11135	upregulated	Sulindac results in increased expression of CDC42EP1 mRNA	22q13.1	A20927
Sulindac	Approved Investigational	CDK1	983	downregulated	Sulindac results in decreased expression of CDK1 mRNA	10q21.2	A24350
Sulindac	Approved Investigational	CDK3	1018	downregulated	Sulindac results in decreased expression of CDK3 mRNA	17q25.1	A20927
Sulindac	Approved Investigational	CDKN1A	1026	upregulated	Sulindac results in increased expression of CDKN1A mRNA	6p21.2	A24352
Sulindac	Approved Investigational	CNNM4	26504	upregulated	Sulindac results in increased expression of CNNM4 mRNA	2q11.2	A20927
Sulindac	Approved Investigational	CPNE1	8904	downregulated	Sulindac results in decreased expression of CPNE1 mRNA	20q11.22	A20927
Sulindac	Approved Investigational	CSNK2A1	1457	downregulated	Sulindac results in decreased expression of CSNK2A1 mRNA	20p13	A20927
Sulindac	Approved Investigational	CSNK2A2	1459	upregulated	Sulindac results in increased expression of CSNK2A2 mRNA	16q21	A20927
Sulindac	Approved Investigational	CYP1A1	1543	upregulated	Sulindac results in increased expression of CYP1A1 mRNA	15q24.1	A24353
Sulindac	Approved Investigational	CYP1A2	1544	upregulated	Sulindac results in increased expression of CYP1A2 mRNA	15q24.1	A24353
Sulindac	Approved Investigational	CYP1B1	1545	upregulated	Sulindac results in increased expression of CYP1B1 mRNA	2p22.2	A24353

Displaying entries 76051 - 76075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability